Production

  1. Bioburden And EU GMP Annex 1: Risk Assessment, Reduction, And Testing

    Experts on regulation, filtration, sampling, and quality control discuss risk assessment and filtration-based strategies to reduce bioburden.

  2. A Conceptual Overview Of The BioSMB MCC Platform 6/7/2021

    In this video, our technology expert Jason Forte describes how the BioSMB system offers 3-5 fold increase in productivity, yielding up to 80% savings on chromatography resin costs with minimal disruption to the accepted ways of doing chromatography today.

  3. Scaling Up A Revolutionary Amorphous Solid Dispersion Platform 3/19/2024

    Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.

  4. Developing Modular Facility Proof-Of-Concept For Multi-Modal Bioprocessing 2/2/2023

    Learn about the innovative solution of designing and constructing manufacturing facilities using predesigned and prefabricated elements.

  5. Transform Your Chromatography Processes With An Innovative Approach 12/2/2024

    Learn how to achieve better resin utilization, minimize disruption to existing methods, and align your strategy with unique process goals.

  6. Reimagine Sustainability In Bioprocessing 4/16/2025

    Achieving sustainability in bioprocessing labs presents distinct challenges. Learn how to reduce your environmental footprint while maintaining efficiency and avoiding extensive re-validation efforts.

  7. UPLC Columns: Fundamentals, Chemistries, And Selected Small-Molecule Applications 10/11/2024

    Discover the fundamentals of UPLC columns and their diverse chemistries. Learn more about versatility in separating small-molecule analytes using reversed-phase and hydrophilic interaction techniques.

  8. Advanced Granulation Technology (AGT) Cell Culture 11/4/2019

    This video is an overview of the most advanced media format available for cell culture - AGT.  A granular dry media format produced through a technologically advanced process which allows manufacturing of complete formulations in a dry format. It can be used in both fed-batch and perfusion cell cultures. AGT dry media is ready-to-use at target pH and osmolality. It is available in complete serum-free, protein-free and chemically-defined media formulations

  9. Showcasing A Scalable Downstream Platform For Multiple AAV Serotypes 10/10/2024

    Watch to explore how to maximize AAV full capsid recovery, establish a scalable platform for various serotypes, and utilize analytical tools to measure empty/full capsid ratios and AAV titers.

  10. Using An Adherent Platform To Scale-Up An Upstream Viral Vector Process 11/20/2024

    Gain insight into a helper-dependent adenovirus (HDAd) process that covers everything from bench-scale and optimization to tech transfer.